The invention relates to 6-substituted isoquinoline and isoquinolinone derivatives of the formula (I)
useful for the treatment and/or prevention of diseases associated with Rho-kinase and/or Rho-kinase mediated phosphorylation of myosin light chain phosphatase, and compositions containing such compounds.
本发明涉及公式(I)的6-取代的
异喹啉和
异喹啉酮衍
生物,可用于治疗和/或预防与Rho-激酶和/或Rho-激酶介导的肌球蛋白轻链
磷酸酶的
磷酸化相关的疾病,以及含有这些化合物的组合物。